Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Harris EN et al. Anticardiolipin antibodies in autoimmune thrombocytopaenia purpura . Br J Haematol 1985; 59: 227-230.

Karpatkin S. Autoimmune thrombocytopaenia purpura. Semin Haematol 1985; 22: 260-288.

Anderson MJ , Peebles CL , McMillan R. , Curd JG Fluorescent antinuclear antibodies and anti-SSA/Ro in patients with immune thrombocytopaenia subsequently developing systemic lupus erythematosus. Ann Intern Med 1985; 103: 548-550 (letter).

Perez HD , Katler E. , Embury S. Idiopathic thrombocytopaenic purpura with hightitre, speckled pattern antinuclear antibodies: possible marker for systemic lupus erythematosus. Arthritis Rheum 1985; 28: 595-597.

Kurata Y. et al. High-titre antinuclear antibodies, anti-SAA/Ro antibodies and antinuclear RNP antibodies in patients with idiopathic thrombocytopaenia purpura . Thromb Haemost 1994; 71: 184-187.

Maddison P. , Mogavero H. , Provost TT , Reichlin M. The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue disorders. J Rheumatol 1979; 6: 189-195.

Galli M. , Finazzi G. , Barlow T. Thrombocytopaenia in the antiphospholipid syndrome. Br J Haematol 1996; 93: 1-5.

Grunow R. et al. The higher efficiency, human B cell immortalising heteromyeloma CB-F7. J Immunol Methods 1988; 106: 257-265.

Menon S. et al. The production, binding characteristics and sequence analysis of four human IgG monoclonal antiphospholipid antibodies. J Autoimmun 1997; 10: 43-57.

10.

Hughes Grv. The antiphospholipid syndrome: ten years on . Lancet 1993; 342: 341-344.

11.

Toubi E. , Khamashta MA , Panarra H. , Hughes Grv. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995; 99: 397-401.

12.

Herranz MT et al. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37: 568-571.

13.

Hunt BJ , Khamashta MA Management of the Hughes syndrome. Clin Exp Rheumatol 1996; 14: 115-117.

14.

Lockshin MD Answers to the antiphospholipid antibody syndrome . N Engl J Med 1995; 332: 1025-1027.

15.

Brey RL Stroke prevention in patients with antiphospholipid antibodies. Lupus 1994; 3: 299-302.

16.

Rosove MH , Brewer Pmc. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117: 303-308.

17.

Khamashta MA et al. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995; 332: 993-997.

18.

Asherson RA , Baguley E. , Pal C. , Hughes Grv. Antiphospholipid syndrome: five year follow-up . Ann Rheum Dis 1991; 50: 805-810.

19.

Hess DC Models for central nervous system complications of antiphospholipid syndrome . Lupus 1994; 3: 353-357.

20.

Kuechle MK , Hutton KP , Muller SA Angiotensin-converting enzyme inhibitor-induced pemphigus: three case reports and literature review. Mayo Clin Proc 1994 ; 69: 1166-1171.

21.

Kaplan RP , Potter TS , Fox JN

Drug-induced pemphigus related to angiotensin-converting enzyme inhibitors. J Am Acd

Dermatol 1992; 26: 364-366.

22.

Gavras I. , Gavras H. Captopril and enalapril. Ann Intern Med 1983 ; 98: 556-557.

23.

Hörkkö S. et al. Antiphospholipid antibodies are directed against epitopes of oxidised phospholipids. J Clin Invest 1996 ; 98: 815-825.

Grand Rounds from International Lupus Centres A young woman with SLE: diagnostic and therapeutic challenges

Abstract

Get full access to this article

References